High Mobility Group A1 Regulates Transcription Levels of Oligodendrocyte Marker Genes in Cultured Oligodendrocyte Precursor Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Feb 2022
Historique:
received: 28 12 2021
revised: 02 02 2022
accepted: 03 02 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 24 3 2022
Statut: epublish

Résumé

Oligodendrocyte precursor cells (OPCs) serve as progenitor cells of terminally differentiated oligodendrocytes. Past studies have confirmed the importance of epigenetic system in OPC differentiation to oligodendrocytes. High mobility group A1 (HMGA1) is a small non-histone nuclear protein that binds DNA and modifies the chromatin conformational state. However, it is still completely unknown about the roles of HMGA1 in the process of OPC differentiation. In this study, we prepared primary OPC cultures from the neonatal rat cortex and examined whether the loss- and gain-of-function of HMGA1 would change the mRNA levels of oligodendrocyte markers, such as

Identifiants

pubmed: 35216347
pii: ijms23042236
doi: 10.3390/ijms23042236
pmc: PMC8878090
pii:
doi:

Substances chimiques

Genetic Markers 0
Hmga1 protein, rat 0
RNA, Messenger 0
RNA, Small Interfering 0
HMGA1a Protein 124544-67-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Institute of Health
ID : R01NS113556

Références

Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):E3558-67
pubmed: 27274063
Neurosci Res. 2016 May;106:66-9
pubmed: 26699082
Mol Cell Neurosci. 2003 Oct;24(2):476-88
pubmed: 14572468
Int J Mol Sci. 2018 Jun 12;19(6):
pubmed: 29895784
J Neurosci. 2015 Oct 14;35(41):14002-8
pubmed: 26468200
Front Cell Neurosci. 2017 Apr 20;11:93
pubmed: 28473753
J Cereb Blood Flow Metab. 2016 Dec;36(12):2034-2043
pubmed: 27742890
Front Cell Dev Biol. 2014 Mar 06;2:5
pubmed: 25364713
Int J Mol Sci. 2020 Jan 06;21(1):
pubmed: 31935816
Development. 1992 Jun;115(2):535-51
pubmed: 1425339
Int J Mol Sci. 2020 Jan 19;21(2):
pubmed: 31963852
Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):14982-7
pubmed: 17855562
Neuron. 1997 Jul;19(1):197-203
pubmed: 9247275
Glia. 2018 Jan;66(1):5-14
pubmed: 28940651
Cells. 2019 Oct 11;8(10):
pubmed: 31614602
Cell Rep. 2016 Apr 26;15(4):748-760
pubmed: 27149841
Nat Neurosci. 2009 Jul;12(7):829-38
pubmed: 19503085
Glia. 2015 Aug;63(8):1350-6
pubmed: 26013243
Neurochem Int. 2014 Nov;77:17-23
pubmed: 24657831
Nat Neurosci. 2008 Sep;11(9):1024-34
pubmed: 19160500
Glia. 2019 Apr;67(4):718-728
pubmed: 30793389
Development. 2017 Sep 1;144(17):3156-3167
pubmed: 28851724
EMBO J. 2006 Oct 18;25(20):4833-42
pubmed: 17006542
Trends Neurosci. 2001 Jan;24(1):39-47
pubmed: 11163886
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17992-7
pubmed: 19815532
J Neurosci. 2006 Oct 25;26(43):10967-83
pubmed: 17065439
J Cell Biol. 2005 May 23;169(4):577-89
pubmed: 15897262
J Cereb Blood Flow Metab. 2010 Feb;30(2):299-310
pubmed: 19826432
Nat Rev Neurosci. 2016 Sep;17(9):537-49
pubmed: 27334043
J Neurosci. 2007 Jul 4;27(27):7339-43
pubmed: 17611286

Auteurs

Naohiro Egawa (N)

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
iPSC-Based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto 619-0237, Japan.
Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8501, Japan.

Gen Hamanaka (G)

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

Kelly K Chung (KK)

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

Hidehiro Ishikawa (H)

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

Akihiro Shindo (A)

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

Takakuni Maki (T)

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.

Ryosuke Takahashi (R)

Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.

Haruhisa Inoue (H)

iPSC-Based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto 619-0237, Japan.
Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8501, Japan.
Medical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto 606-8507, Japan.

Eng H Lo (EH)

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

Ken Arai (K)

Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH